The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Funding and acquisitions in Indian startups this week [Oct 12- Oct 17].
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver
City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders. The post City Therapeutics’ Upsized IPO Raises $200M to Bri…
Follow the full firehose on the HTC Wire, refreshed automatically every day.
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.